Retained Earnings (Accumulated Deficit) of DICE Therapeutics, Inc. from 31 Dec 2020 to 30 Jun 2023

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
DICE Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Dec 2020 to 30 Jun 2023.
  • DICE Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending 30 Jun 2023 was $248,056,000, a 72% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

DICE Therapeutics, Inc. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $248,056,000 -$104,236,000 -72% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $213,240,000 -$90,942,000 -74% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $187,594,000 -$83,887,000 -81% 31 Dec 2022 10-Q 08 Aug 2023 2023 Q2
Q3 2022 $164,370,000 -$76,858,000 -88% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $143,820,000 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $122,298,000 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $103,707,000 -$48,959,000 -89% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $87,512,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q4 2020 $54,748,000 31 Dec 2020 10-K 28 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.